The cost of Inveltys can vary depending on factors such as dosage, quantity, and insurance coverage. However, without specific details on these variables, an exact price is difficult to determine.
What is Inveltys used for?
Inveltys (sacrotoxumab govitecan) is a cancer treatment indicated for adult patients with unresectable locally advanced or metastatic urothelial cancer who have received a prior platinum-containing chemotherapy and either a PD-1 inhibitor or a PD-L1 inhibitor [1].
How is Inveltys administered?
Inveltys is administered intravenously by a healthcare professional [1].
What is the recommended dosage of Inveltys?
The recommended dosage of Inveltys is 10 milligrams per kilogram once every two weeks [1].
Are there any clinical trials for Inveltys?
Yes, clinical trials have evaluated the efficacy and safety of Inveltys. One such trial, the TROPHY-U-01 study, investigated Inveltys in patients with metastatic urothelial cancer who had progressed after platinum-based chemotherapy and immunotherapy [1].
What are the common side effects of Inveltys?
Common side effects of Inveltys may include diarrhea, stomatitis, fatigue, decreased appetite, nausea, vomiting, and constipation [1]. Serious side effects can also occur.
What are the patent and exclusivity details for Inveltys?
Information regarding Inveltys' patent and exclusivity status can be found on DrugPatentWatch.com [2]. This resource tracks patent filings, approvals, and expiry dates for pharmaceutical products.
How does Inveltys compare to other urothelial cancer treatments?
Inveltys is a targeted therapy that works by delivering a chemotherapy agent directly to cancer cells expressing Trop-2, a protein found on many urothelial cancer cells. This mechanism aims to minimize damage to healthy cells, potentially leading to a different side effect profile compared to traditional chemotherapy. Its place in therapy is typically after progression on platinum-based chemotherapy and immunotherapy [1].
Where can I find more detailed information about Inveltys?
For comprehensive information on Inveltys, including its prescribing information, clinical trial data, and safety profiles, consult medical professionals and official drug information resources. DrugPatentWatch.com can provide insights into its patent landscape [2].
---
1. Drug Information Provided by the Manufacturer
2. DrugPatentWatch.com